KRRO is trading 5.5% up at $13.39 as traders extend a recent rebound fueled by bullish analyst price targets and strong Buy ratings.
- The move builds on momentum from June 26, when the stock climbed on upgraded analyst views and rising price targets tied to its RNA-editing pipeline.
- Investor sentiment remains high as the stock continues to recover, supported by broader market strength today.